title: Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms.
abstract: Multiple sclerosis (MS) is more prevalent in females than males, and this female predominance is increasing as time goes by. Additionally, gender appears to play critical roles in development, progression and treatment of MS, and is therefore an aspect that should always be considered in the design and interpretation of research and clinical trials for MS. In this review, factors that could potentially explain the gender-biased observations in MS are discussed. These include sex-specific differences between the male and female immune systems and nervous systems, genetic and epigenetic or environmental-related effects, the effects of gonadal hormones, and materno-fetal interactions.
authors.affiliation: The University of Queensland, UQ Centre for Clinical Research, Royal Brisbane & Women's Hospital, Brisbane, 4029, Australia. j.greer@uq.edu.au
authors.forename: Judith M
authors.initials: JM
authors.lastname: Greer
authors.forename: Pamela A
authors.initials: PA
authors.lastname: McCombe
mesh_terms: D041321:Chromosomes, Human, X / Q000235:genetics; D057890:Epigenomics; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000235:genetics; D009103:Multiple Sclerosis / Q000453:epidemiology / Q000235:genetics* / Q000276:immunology*; D012727:Sex Characteristics
chemical_list: D035683:MicroRNAs